INC.

SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023

by

PHOENIX, May 15, 2023 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners Spring 2023 Investor Conference, taking … Read more

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

by

SALT LAKE CITY, May 15, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S. Dr. Critchfield is retiring after 12 years … Read more

Natural Alternatives International, Inc. Announces 2023 Q3 and YTD Results

by

CARLSBAD, Calif., May 15, 2023 /PRNewswire/ — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.4 million, or $0.41 per diluted share, on net sales of $32.7 million for the third quarter of fiscal year 2023 compared to net income of $2.5 … Read more

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

by

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., May 15, 2023 /PRNewswire/ — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, … Read more

Alliance Creative Group (ACGX) Reports First Quarter of 2023 Financials with Over $4,000,000 in assets

by

The transition for ACG is making progress in 2023 CHICAGO, May 15, 2023 /PRNewswire/ — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months and Quarter Ending March 31, 2023. Revenues for the quarter ending March 31, 2023 (“Q1 2023”) were $845,676 Gross … Read more

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

by

TORRANCE, Calif., May 15, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023. Recent Highlights “We enjoyed a fifth straight increase in … Read more

SilverSneakers Opens Nominations for 2023 Member of the Year

by

Annual awards honor seniors whose commitment to well-being inspires and champions others to live healthier lives as they age CHANDLER, Ariz., May 15, 2023 /PRNewswire/ — SilverSneakers® by Tivity Health®, the nation’s leading community fitness program for older Americans, announced today it is accepting nominations for the 19th annual SilverSneakers Member of the Year Award. … Read more

New Data Published on Biosense Webster QDOT MICRO™ Catheter

by

Showed high clinical success with 86% freedom from symptomatic recurrence1 Temperature control allows for the safe use of higher RF power in short bursts, enhancing efficacy and efficiency without compromising safety1 IRVINE, Calif., May 15, 2023 /PRNewswire/ — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced … Read more

U.S. Renal Care Raises $328 Million of New Capital to Accelerate Growth

by

PLANO, Texas, May 15, 2023 /PRNewswire/ — U.S. Renal Care (USRC or “the Company”), the nation’s largest privately held and fastest growing kidney care provider, today announced that it has successfully raised $328 million in new capital to further accelerate the Company’s growth and expansion plans. The new capital will be invested in programs focused on innovation … Read more

Sorrento Therapeutics, Inc.’s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers’ Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts

by

SAN DIEGO, May 14, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that, in connection with its ongoing chapter 11 case, the U.S. Bankruptcy Court for the Southern District of Texas (the “Bankruptcy Court”) … Read more